It looks like you're using an unsecure version of Internet Explorer. Using an outdated browser makes your computer unsafe. For the best and safest website experience, please update your
or please use
Management of type 2 diabetes: simplicity of Trajenta (linagliptin) for a broad range of patients (Promotional content from Boehringer Ingelheim) | GPnotebook TV
This site is intended for UK healthcare professionals
This video presentation has been organised and funded by Boehringer Ingelheim
Management of type 2 diabetes: simplicity of Trajenta (linagliptin) for a broad range of patients (Promotional content from Boehringer Ingelheim)
1 October 2020
Click here to access the Trajenta prescribing information
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone).
The content of this website is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. Any distribution or duplication of the information contained herein is strictly prohibited.